Akiram Therapeutics
Advancing radiotherapeutics to treat solid tumors
4 employees · est. 2021 · Uppsala, Sweden
Tempus AI
Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine.
3153 employees · est. 2015 · Chicago, United States
Tempus AI is the older company (2021 vs 2015); Tempus AI is the larger of the two.
Side-by-Side Comparison
| Metric | Akiram Therapeutics | Tempus AI |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2015 older |
| Headquarters | ||
| Headquarters | Uppsala, Sweden | Chicago, United States |
| Employees | ||
| Employees | 4 | 3153 larger |
| Industry | ||
| Industry | Biotechnology, Life Sciences | AI, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Debt |
| Total Funding | ||
| Total Funding | Not tracked yet | $1.64B |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 15 |
| Services | ||
| Services | Not tracked yet | AI-Enabled Healthcare Solutions, Diagnostic Tools Development, Healthcare Data Analytics, Research Program Partnerships |
| Target Customers | ||
| Target Customers | Not tracked yet | Healthcare Providers, Research Institutions, Medical Professionals, Healthcare Researchers |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Precision Medicine, Multimodal Data, Clinical Data Interpretation, Molecular Data Analysis, Personalized Patient Care, Therapeutics Development, AI-Enabled Healthcare Solutions, Patient Data Utilization, Healthcare Operating Systems, Medical Data Libraries, Healthcare Innovation |
| Website | ||
| Website | akiramtherapeutics.se | tempus.com |
About Akiram Therapeutics
Akiram Therapeutics is a Swedish biotech company focused on advancing radiotherapeutics to treat solid tumors. The company's unique approach involves combining a radiation component with a proprietary antibody to deliver radioactivity directly to cancer cells while minimizing damage to surrounding h...
About Tempus AI
Tempus AI, Inc. (NASDAQ: TEM) is at the forefront of integrating artificial intelligence into the healthcare sector, emphasizing the power of precision medicine. Since its founding in 2015, Tempus has focused on building one of the largest libraries of multimodal medical data globally, ensuring that...
We will tell you when either one moves
BounceWatch watches Akiram Therapeutics and Tempus AI for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Akiram Therapeutics and Tempus AI — by email.
Frequently Asked Questions
Compare Akiram Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Tempus AI on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
